Journal article
Anti–NMDA Receptor Encephalitis
Abstract
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a severe but potentially reversible neurologic disorder that is clinically recognizable in children and adolescents. Prompt diagnosis and treatment are essential to facilitate recovery. Treatment consists of corticosteroids, intravenous immunoglobulin, or plasma exchange as first-line therapy followed by cyclophosphamide or rituximab, if necessary, as second-line immunotherapy. Patients …
Authors
Jones KC; Benseler SM; Moharir M
Journal
Neuroimaging Clinics of North America, Vol. 23, No. 2, pp. 309–320
Publisher
Elsevier
Publication Date
May 2013
DOI
10.1016/j.nic.2012.12.009
ISSN
1052-5149
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdolescentAdrenal Cortex HormonesAnti-N-Methyl-D-Aspartate Receptor EncephalitisAutoantibodiesBrainChildEarly DiagnosisEarly Medical InterventionHumansImage EnhancementImage Interpretation, Computer-AssistedImmunization, PassiveImmunosuppressive AgentsMagnetic Resonance ImagingPlasma ExchangeReceptors, N-Methyl-D-Aspartate